Intersect ENT recalls

Intersect ENT has 2 recalls on record with the FDA and USDA, the earliest in 2022 and the latest reported on 25 Jan 2023. 1 is still ongoing. The most frequent reason is potency & assay.

Total recalls2since 2022

Last 12 months0reported

Class I00% of total

Ongoing1latest 25 Jan 2023

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 1 50%Class III 1 50%

Why intersect ent is recalled

Potency & Assay150%
Packaging Defects150%

Product types

Other Medical Devices150%

By year

2023150%
2022150%

Ongoing intersect ent recalls

1 active

Reported	Class	Recall	Company	Reason	Where
14 Dec 2022Device	CLASS II	Propel Mini Mometasone Furoate Sinus Implant recalled by Intersect ENT	Intersect ENT	Packaging Defects	Nationwide

All intersect ent recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
25 Jan 2023Drug	CLASS III	Sinuva (mometasone furoate) sinus implant, 1350 mcg, 1 implant recalledSinuva	Intersect ENT	Potency & Assay	Nationwide
14 Dec 2022Device	CLASS II	Propel Mini Mometasone Furoate Sinus Implant recalled by Intersect ENT	Intersect ENT	Packaging Defects	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.